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Type 1 diabetes (T1D) is a T cell mediated autoimmune disease that targets and destroys 
insulin-secreting pancreatic beta cells. Beta cell specific T cells are highly differentiated and 
show evidence of previous antigen exposure. Exercise-induced mobilisation of highly-
differentiated CD8+ T cells facilitates immune surveillance and regulation. We aimed to 
explore exercise-induced T cell mobilisation in T1D. In this study, we compared the effects 
of a single bout of vigorous intensity exercise on T cell mobilisation in T1D and control 
participants. N=12 T1D (mean age 33.2yrs, predicted VO2 max 32.2 mL/(kg·min), BMI 
25.3Kg/m2) and N=12 control (mean age 29.4yrs, predicted VO2 max 38.5mL(kg.min), BMI 
23.7Kg/m2) male participants completed a 30-minute bout of cycling at 80% predicted VO2 
max in a fasted state. Peripheral blood was collected at baseline, immediately post-exercise, 
and 1 hour post-exercise. Exercise-induced mobilisation was observed for T cells in both 
T1D and control groups. Total CD8+ T cells mobilised to a similar extent in T1D (42.7%; 
p=0.016) and controls (39.7%; p=0.001). CD8 effector memory CD45RA+ (EMRA) subset 
were the only T cell lineage subset to be significantly mobilised in both groups though the 
percentage increase of CD8+ EMRA was blunted in T1D (T1D (26.5%) p=0.004, control 
(66.1%) p=0.010). Further phenotyping of these subsets revealed that the blunting was most 
evident in CD8+ EMRA that expressed adhesion (CD11b: T1D 37.70%, Control 91.48%) and 
activation markers (CD69: T1D 29.87%, Control 161.43%), and appeared to be the most 
differentiated (CD27-CD28-: T1D 7.12%, Control 113.76%). CD4+ T cells mobilised during 
vigorous intensity exercise in controls (p=0.001), but not in T1D. The blunted mobilisation 
response of particular T cell subsets was not due to CMV serostatus or apparent differences 
in exertion during the exercise bout as defined by heart rate and RPE. Predicted VO2 max 
showed a trend to be lower in the T1D group than the control group but is unlikely to 
contribute to this blunted response. We postulate the reasons for a blunted mobilisation of 
differentiated CD8+ EMRA cells includes differences in blood glucose, adrenaline receptor 
density, and sequestration of T cells in the pancreas of T1D participants. In conclusion, 
mobilisation of CD8+ EMRA and CD4+ subsets T cells is decreased in people with T1D 
during acute exercise.  
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INTRODUCTION 
Type 1 Diabetes (T1D) is an autoimmune disorder characterised by T cell mediated 
destruction of insulin secreting pancreatic beta cells. Peripheral T cells are mobilised by acute 
exercise in health, and exercise may also modulate the number and function of these cells. 
We therefore wished to explore the effect of exercise on T cell mobilisation in people with 
T1D.  
 
T cells in T1D 
Beta cell specific T cell subsets are mainly comprised of late differentiated memory T cells 
that show evidence of previous antigen exposure [1-3]. Indeed, circulating islet specific CD8+ 
T cells have been detected at similar frequencies in both T1D and non-diabetic cohorts [4]. 
However, antigen-experienced islet reactive CD8+ T cells (ZnT8186–194 multimer+) were found 
sequestered in the pancreas of T1D donors, but not non-diabetic donors [4]. Islet resident 
CD8+ T cells in the human pancreas also express CD11b, CD69, and CD103, which are 
markers of tissue resident memory cells [5-7]. In particular, elevated highly differentiated 
CD8+ effector memory T cells re-expressing CD45RA (EMRA) have been found in T1D [1, 
2, 8].  
 
T cell differentiation 
Re-expression of CD45RA on fully differentiated effector memory (EM) T cells (EMRA) is 
the final stage of T cell differentiation in the T cell lineage pathway [9] (Figure 1), which 
gives rise to a range of phenotypically and functionally diverse T cell subsets. This re-
expression of CD45RA leads to a more stable resting memory T cell pool that can respond to 
recall antigens [10, 11]. Differentiation status of EMRA subsets can be identified in a number 
of ways; cell surface expression of markers such as CD26, CD57, and killer cell lectin-like 
receptor subfamily G member 1 (KLRG1) [1, 2, 8]; lack of CD27 and CD28 expression [12, 
13]; and evidence of shortened telomeres indicative of successive rounds of cell division [2, 
8]. Although conventionally EMRA are CD27-CD28-, there is evidence of further 
subdivisions of differentiation based on the differential expression of these markers [14]. 
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Pedro Romero et al., 2007 identified small subpopulations of CD27-CD28+ and CD27+CD28- 
EMRA [14]. Nonetheless, CD27+CD28+ and CD27-CD28- EMRA make up the larger 
proportion of EMRA subpopulations [14, 15].  
Towards the beginning of the linear differentiation pathway, CD8+ T cells are released into 
the circulation as naïve T cells which are characterised by their cell surface co-expression of 
CD45RA, CCR7, CD27 and CD28 [16-21]. CD45, the leukocyte common antigen, has 
multiple isoforms which are differentially expressed based on maturation status [22]. Central 
memory (CM) cells are formed (CD45RA-CCR7+) following antigen experience and loss of 
CD45RA [18, 21]. Memory cells lose the expression of the high molecular weight CD45RA 
isoform and gain expression of the low molecular CD45RO isoform following activation 
[23]. Following antigen presentation, CM T cells can rapidly differentiate into T cells with 
effector functions [20]. CCR7 is down-regulated as CM T cells become specialised, antigen 
specific effector T cells. CM T cells progress to effector memory (EM) T cells through three 
progressively differentiated subpopulations defined based on their expression of CD27 and 
CD28: early differentiated (ED) (CD27+CD28+), early-like differentiated (ELD) (CD27-
CD28+), and intermediate differentiated (ID) (CD27+CD28-). CD27 and CD28 diminish in a 
stepwise fashion following successive rounds of differentiation in response to antigen 
stimulus, corresponding with an increase in cytotoxic functions [12, 13, 24]. Following the 
loss of both CD27 and CD28, ID T cells become fully differentiated EM T cells (CD27-
CD28-) [24, 25].  
Amidst these earlier stages of differentiation exists a dynamic population CD8+ T cells which 
have recently been implicated in T1D [2, 3]. Stem cell like memory T cells (TSCM) 
(CD27+CD45RO-CD95+CCR7+) express naïve surface markers (CD45RA, CCR7) and are 
capable of extensive proliferation and self-renewal, similar to hematopoietic stem cells [26-
28].  However, TSCM also have the ability to rapidly acquire effector functions upon 
stimulation and respond to recall antigens, analogous to effector memory subsets [28, 29]. 
Beta cell specific T cell populations in the peripheral blood have been identified with this 
phenotype in T1D, indicating a role for TSCM in the pathogenesis of the disease [2, 3]. 
In addition to progressive differentiation of CD8+ T cell lineage subsets, CD4+ T cells are 
characterised in a similar manner (Figure 1).  However, in addition to this phenotypic 
approach, CD4+ T cells are also defined based on their differentiation into T-helper (Th) 
(CD45RO+CD127hiCD25low) and T-Regulatory (TRegs) (CD4+CD127lowCD25+) subsets [17, 
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30]. The T-helper subpopulations are distinguished by chemokine receptor expression and 
cytokine secretion patterns [17, 31-33]. These include type 1 helper (Th1) cells [17, 34, 35], 
type 2 helper (Th2) [17, 34], Th9 [36], Th17 [17, 37-39], and Th22 cells [36]. CD4+ TReg 
subpopulations consist of naïve (naTRegs) and memory TRegs (mTRegs). As described for 
lineage T cell subsets, naTRegs express CD45RA whereas mTRegs lose CD45RA and 
acquire CD45RO upon antigen exposure [18, 40]. mTRegs are an activated antigen primed 
subset of CD4+ TRegs [41, 42]. mTREGs express TIGIT, a coinhibitory molecule [43], 
which supress pro-inflammatory Th1 and Th17 cells, but promote Th2 cell responses and 
therefore support an anti-inflammatory environment [43]. In T1D, there is strong evidence to 
suggest that the balance between T-helper and TRegs is disrupted. CD4+ Th differentiation is 
skewed towards increased pro-inflammatory Th1 and Th17 cells [44, 45]. Whereas CD4+ 
TReg function, and potentially TReg frequency, are compromised in T1D [46]. This 
increases immune dysregulation already upheld by memory CD8+ T cell subsets.  
Acute exercise and T cell mobilisation 
To date, the effects of acute exercise on T cells, including those implicated in T1D 
pathogenesis, outlined above, have not been investigated. In healthy individuals, acute 
exercise induces a significant increase in the T cell frequency, proportional to exercise 
intensity, in the peripheral blood immediately following exercise.  
The largest mobilisation within T cells is seen among CD8+ T cells, with minimal CD4+ T 
cell mobilisation [47-50]. Although mobilisation of CD4+ T cells is minimal, there is 
evidence to support that exercise induces a shift from Th1 to Th2 polarization, reducing pro-
inflammatory CD4+ T cell phenotypes [6, 7, 79-81]. Within the CD8+ T cell compartment, 
CD8+ T cells with a highly differentiated memory phenotype are preferentially mobilised 
following exercise [50-55]. CD8+ EMRA have been reported to increase by 450% following 
vigorous exercise compared to naïve CD8+ T cells which increased by 84% [51]. Further 
studies show that CD8+ effector memory (EM) and EMRA that exhibited the largest increase 
following exercise were fully differentiated (CD27-CD28-) [52] and expressed markers of 
terminal differentiation and senescence (killer cell lectin-like receptor subfamily G member 1 
(KLRG1)+CD57+) [53]. Whilst the cells detectable in the T1D pancreas express markers of 
differentiation, memory and residency [4-7], the effects of acute exercise on the mobilisation 
of these T cell subsets in T1D is yet to be explored.  
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Investigating the effects of exercise on T cell subsets in T1D may be critical for the 
understanding and treatment of this disease. Lymphocytosis is followed by intensity-
dependent lymphopenia in the period that follows a bout of exercise [47-49, 56-58]. 
Following the dramatic increase in CD8+ EM and EMRA frequency following exercise, it is 
these same subsets which exhibit the largest egress from the peripheral blood during the 
recovery period [52, 53]. This flux may play a role in immune regulation. Tissue 
redistribution of lymphocytes is one cause of exercise-induced lymphopenia [58]. Krüger et 
al. 2007 demonstrated using fluorescent cell tracking in mice that T cells were released from 
the spleen and accumulated in the lungs, bone marrow, and Peyer's patches of the mice 
following acute exercise [59]. Such movement of immune cells may support immune 
surveillance. Post-exercise lymphopenia is also thought to result partially from lymphocyte 
apoptosis [60-62]. Acute exercise, particularly of vigorous intensity (i.e. above 70% VO2 
max), mobilises CD95+ memory T cells [60, 63]. It has been postulated that CD95 expression 
may indicate an apoptotic fate and subsequently create “immunological space” [64, 65]. The 
percentage of apoptotic lymphocytes as well as CD95+ T cells increases following exhaustive 
exercise (80% VO2 max) in healthy participants. [60, 62, 63]. Furthermore, mice subjected to 
a strenuous 90-minute treadmill running protocol showed a decrease in CD8+ T cells 24 
hours following exercise, and apoptosis of intestinal CD8+ T cells was higher 24 hours after 
exercise [61]. It is hypothesised that this vacant immune space following exercise can be 
taken up by newly generated immature cells, creating the opportunity to reprogram immune 
memory. In support of this, vigorous acute exercise increases hematopoietic stem and 
progenitor cells (HSPC) post-exercise as well as stimulates haematopoiesis [66, 67].  
Exploring the effects of acute exercise on T cells in T1D 
Given that acute exercise mobilises CD8+ T cells with a highly differentiated phenotype that 
express markers of tissue residency, and that CD8+ T cells with this phenotype are thought to 
sustain beta cell destruction in T1D, it is important to explore the impact of acute exercise on 
these T cell subsets in T1D. A limited amount of research has been conducted in exercise 
training in T1D. Exercise training in streptozotocin-induced T1D mice significantly increased 
insulin content and insulin secretion compared to sedentary mice [68]. Furthermore, exercise 
training in non-obese diabetic (NOD) mice reduced immune cell infiltration into the pancreas 
and subsequently the insulitis index. This is the only exercise study in a model of T1D to 
demonstrate the modulatory effects of exercise on islet immunity [69]. We therefore aimed to 
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provide a comprehensive phenotypic characterisation of exercise-induced mobilisation of 
potentially pathogenic T cell subsets in T1D, and compare this response to that observed in 
healthy participants.  
METHODS 
Participants 
Ethical approval was granted by the Preston Research Ethics Committee (REC) for this 
study. Twelve controls and twelve T1D participants were recruited. All participants were 
male and between 16-65 years of age. Male only participants were chosen to minimise 
differences in immunity evident in females due to higher oestrogen levels [70-72]. Participant 
baseline characteristics are reported in table 1. T1D participants had a clinical diagnosis of 
T1D, were on basal bolus insulin regime or insulin pump therapy, competent in carbohydrate 
content estimation of meals, were willing to test glucose through capillary testing, and were 
able to recognise hypoglycaemic symptoms before blood glucose fell to 3.9mmol/L. 
Participants did not have a history of cardiac disease or other significant illness that would 
prevent attendance at the study sit. All T1D participants did not have active proliferative 
diabetic retinopathy, autonomic neuropathy, or history of severe hypoglycaemia requiring 
third party assistance within the last 3 months prior to the study. 
Experimental design 
Participants had one enrolment visit, where baseline demographics and anthropometric 
assessment was carried out (table 1). During the enrolment visit, each participant completed a 
non-fasted incremental sub-maximal (85% HRmax) cycle ergometer test to calculate their 
predicted VO2 max. This was used to calculate workload and heart rate for the subsequent 
exercise visit adjusted to individual fitness [73]. The enrolment visit and exercise visit were 
separated by one week. Participants were asked to abstain for vigorous exercise 24 hours 
prior to the exercise visit. Participants were also required to record a food diary for the 24 
hours prior to the exercise visit. Participants were advised to use these diaries to ensure that 
the same foods were consumed in the 24 hours prior to each exercise bout.  . The exercise 
visit started at 8.30am for all participants and consisted of a thirty-minute bout of cycling at 
80% predicted VO2 max. An initial fasting blood sample was taken for each participant once 
the cannula was inserted. The participant was then allowed to rest for a further 20 minutes 




intravenously at immediately pre-exercise, immediately post-exercise, and 1 hour post-
exercise.  Pre- and post-exercise samples were taken whilst the participant was sitting on the 
cycle ergometer and sampling was strictly timed using a stopwatch. All participants 
completed an international physical activity questionnaire (IPAQ) [74] and perceived stress 
questionnaires; the life scale events questionnaire [75], perceived stress scale [76], the 
undergraduate stress questionnaire [77], self-perceived health status [78], and the Pittsburgh 
sleep quality index [79]. 
Sample processing 
All blood samples were processed under identical conditions using the same laboratory 
reagents and apparatus. Blood samples for immunophenotyping analysis were taken in 
lithium heparin vacuette tubes (95057-405, Greiner Bio-one GmbH, Frickenhausen, 
Germany) and placed on roller at room temperature to ensure constant mixing of the blood 
sample until processing. All sample processing was initiated within 2 hours of blood-draw. 
Haematological measures were conducted on 25μl of whole blood using an automated coulter 
counter (ABX Micros ES 60, HORIBA Medical). Relative cell number (cells/μl) of T cell 
subsets was then calculated from this.   
Whole blood staining 
The whole blood staining protocol was optimised prior to the start of the study. The protocol 
was adapted from the Clinical Immunology Service, University of Birmingham. Red blood 
cells were lysed by preparing whole blood in 4ml aliquots and washed with 16mls 
Ammonium Chloride lysis buffer (16g Ammonium Chloride (326372, Sigma-Aldrich, 
Dorset, UK), 2g sodium hydrogen carbonate (S/4240/60, Fisher scientific Ltd, 
Loughborough, UK), 0.2g EDTA (E5134, Sigma-Aldrich, Dorset, UK), and 2L ddH2O). The 
sample was centrifuged at 1000g for 5 minutes. Pelleted cells were resuspended in 10mls 
RPMI-1640 (R0833, Sigma-Aldrich, Dorset, UK) (supplemented with 2% FBS) and 
centrifuged at 1000g for 5 minutes. Cells were then counted and resuspended to a 
concentration of 1x106 cells/ml. Cells were stained with appropriate antibodies and incubated 
in dark at 4°C for 20minutes. Stained cells were lysed and fixed with 500µl 1X BD FACS 
lysing solution (containing 14% formaldehyde) (349202, BD Biosciences, Wokingham, UK) 
and incubated in dark at 4°C for a further 15minutes. Fixed cells were washed (centrifuged at 
1000g for 5 minutes) in 2mls phosphate-buffered saline (PBS). Pelleted cells were 
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resuspended in 500µl PBS and stored at 4°C until flow cytometry analysis. The stability of 
fixed stains was assessed and confirmed that cells could be stored up to 24hours at 4°C 
before flow cytometry analysis. All samples were analysed using BD LSR Fortessa X-20. 
Parent populations (i.e. lymphocytes) were selected based on their size on FSC/SSC dot 
plots. Doublets were omitted by selecting the linear population shown on FSC-A/FSC-H dot 
plots prior to recording. Events to record were set to 100,000 within the parent population 
gate. Compensation was carried out monthly using compensation beads and single stained 
cells. The most recent compensation set up was linked to each experiment. A negative control 
(unstained whole blood) was run for each experiment.  
T cell subset analysis 
Individual T cell phenotypes along the linear differentiation pathway of CD4+ and CD8+ T 
cells (Figure 1), as well as CD4+ T-helper (Th) and T-Regulatory (TReg) subsets following 
an acute bout of vigorous intensity exercise (80% predicted VO2 max) were measured in T1D 
and healthy participants. Two multi-colour flow cytometry panels were designed to 
phenotype lineage T cell subsets (panel 1) and CD4 T-helper/T-Regulatory subsets (panel 2) 
using the following anti-human monoclonal antibodies (mAbs) obtained from BD 
Biosciences (Wokingham, UK) (unless stated otherwise): Panel 1 anti-CD3 PE-Cy7 
(UCHT1), anti-CD4 APC-R700 (RPA-T4), anti-CD8 APC-H7 (SK1), anti-CD11b PE-CF594 
(ICRF44), anti-CD27 BB515 (M-T271), anti-CD28 BV510 (CD28.2), anti-CD45RA BV786 
(HI100), anti-CD69 BV650 (FN50), anti-CD95 BV421 (DX2), anti-CD127 AF647 (HIL-7R-
M21), anti-CCR7 PE (3D12), anti-7-AAD PerCP-Cy5.5. Panel 2 anti-CD3 PE-Cy7 
(UCHT1), anti-CD4 APC-R700 (RPA-T4), anti-CD25 PE (M-A251), anti-CD45RO BV786 
(UCHL1), anti-CD127 AF647 (HIL-7R-M21), anti-CXCR3 PE-CF594 (1C6), anti-CCR4 
BV421 (1G1), anti-CCR6 BV711 (11A9), anti-IL-6R FITC (AS12), anti-TIGIT PerCP-Cy5.5 
(MBSA43) (eBioscience, San Diego, CA, US), and Live/Dead-Fixable Viability Stain 780.  
Data analysis 
Flowjo version 10 (FlowJo LLC, Oregon) was used to analyse flow cytometry data. Doublets 
were removed using FSC-A versus FSH-H dot plots. Dead cells positive for 7-AAD viability 
stain were removed, and lymphocytes were selected based on size on SSC-A versus FSC-A 
dot plots. Total T cells were selected as CD3+, and further selected as separate CD4+ and 
CD8+ populations. Spider gates were used within CD4+ and CD8+ populations to define 
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distinct progressively differentiated subsets as outlined in supplementary Figure 1; naïve 
(CD45RA+CCR7+), TSCM (CD45RA+CCR7+CD95+CD127+), central memory (CM: CD45RA-
CCR7+), effector memory (EM: CD45RA-CCR7-), early differentiated (ED: CD45RA-CCR7-
CD27+CD28+), early-like differentiated (ELD: CD45RA- CCR7- CD27-CD28+) and 
intermediately differentiated (ID: CD45RA- CCR7-CD27+CD28-), and effector memory re-
expressing CD45RA (EMRA: CD45RA+CCR7-). The gating strategy for TSCM is displayed in 
supplementary Figure 2. Single cell surface expression of CD69, CD11b, CD127, and CD95 
was gated on CD4 and CD8 naïve, CM, EM, and EMRA T cell subsets.  
CD4+ T cells were further divided into T-helper (supplementary Figure 3) and T-Regulatory 
(supplementary Figure 4) subsets; CD4+ T-Regulatory (CD127loCD25hi), naïve T-Reg 
(CD45RO-CD127loCD25hi), memory T-Reg (CD45RO-CD127loCD25hi), T-helper (Th: 
CD127+CD25-CD45RO+), Th1 (CXCR3+CCR6+CCR4-), Th2 (CXCR3-CCR6-CCR4+), and 
Th17 (CXCR3-CCR6+CCR4+).  
Statistical analysis 
Statistical analysis was performed using SPSS version 24 (IBM, Chicago) and GraphPad 
Prism version 7 (GraphPad Software, California). Firstly, normality tests were performed on 
all data using Q-Q plots in SPSS. Data which was not normally distributed was logged and 
normality tests were repeated, confirming all subsets to have normal distribution. Multiple 
regression analysis was used to analyse within subject’s effect (time) and between subject’s 
effects overtime (time*group). Main effects of exercise are described as changes over time. 
Changes immediately post-exercise and 1 hours post-exercise are compared to baseline 
values and are reported in tables for each group under the heading “contrast”. P values were 
reported as sphericity assumed however where mauchly’s test of sphericity was violated i.e. p 
0.05, Greenhouse-Geisser corrected value was used. Student T-tests were performed on 
baseline characteristics. The p values, F values, and degrees of freedom (df) are reported in 
tables as [F = (df, df error) value, p-value]. Variation in n numbers is a result of a participant 
having no data for 1 hour post-exercise time-point. Data are presented in tables as mean ± 
standard deviation (SD) unless otherwise stated. P values 0.05 were considered significant. 
Significantly mobilised subsets in control and T1D groups, but blunted in T1D, are presented 




Participants anthropometric and physiologic characteristics are shown in table 1. No 
statistically significant differences between groups were found for anthropometric and 
physiologic characteristics. The results obtained for CD8+ lineage subpopulations are 
summarized in tables 2-3. CD4+ T-Regulatory and T-helper subpopulations are summarized 
in table 4. Extensive T cell subpopulations analysis is included in supplementary tables 1-3.   
The mobilisation CD8+ EMRA T cells is blunted in T1D during vigorous intensity 
exercise 
Lymphocytosis and CD8+ T cell mobilisation occurs in both T1D and control groups as 
summarized in supplementary table 1. However, the most dramatic changes were observed 
within the CD8+ lineage subsets (depicted in Figure 1) during vigorous intensity exercise in 
T1D and control participants. The results for CD8+ lineage subsets are displayed in table 2. 
As anticipated, within the CD8+ T cell populations, less differentiated cells such as naïve, 
TSCM, and CM subsets did not significantly change with exercise in either group. As 
expected, significant changes were however observed in the more differentiated subsets such 
as CD8+ ED, ELD, ID, EM, and EMRA subsets during vigorous exercise. Therefore, the 
increase in CD8+ T cells is driven by mobilisation of later differentiated CD8+ T cell subsets, 
and these changes were most significant in the CD8+ EMRA subsets for each group.  
Although statistically significant changes in CD8+ TSCM were not observed during vigorous 
intensity exercise in either group, increases in the number CD8+ TSCM immediately post-
exercise were suggested in both control and T1D participants (table 3). However, during 
vigorous intensity exercise a blunted response is noted in the T1D group. CD8+ TSCM 
decreased following vigorous exercise by 90.97% in the T1D group but increased 
dramatically by 1898.69% in the control group. It is worth noting that the total cell numbers 
for CD8+ TSCM subsets were very small.  
Within the later differentiated subsets, CD8+ ED significantly changed during vigorous 
intensity exercise overall only (p=0.040), but this was not seen in either T1D or control 
groups independently. There was an overall change in CD8+ ELD during vigorous intensity 
exercise (p<0.001), with a non-significant trend to change in the T1D group (p=0.054) but 
not in the control group. This change was driven by an increase in CD8+ ELD post-exercise 
followed by a significant decrease below baseline in CD8+ ELD 1 hour post vigorous 
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exercise in the T1D group only (p=0.029). CD8+ ID significantly changed over time with 
vigorous exercise (p<0.001) but not in either T1D or control groups independently. CD8+ ID 
significantly decreased below baseline 1 hour post vigorous exercise in the control group 
only (p=0.027). CD8+ EM showed a trend to mobilise during vigorous exercise (p=0.067), 
driven by a trend to increase post-exercise, with a decrease below baseline at 1 hour post-
exercise (p=0.040) in the T1D group. No significant changes were observed for CD8+ EM in 
the control group.  
Finally, CD8+ EMRA cell frequency significantly changed overall during vigorous intensity 
exercise (p=0.001). CD8+ EMRA were significantly mobilised by vigorous intensity exercise, 
driven by a trend to increase post-exercise, in T1D (p=0.004) and control groups (p=0.010). 
There was a significant decrease 1 hour post-exercise in both T1D (p=0.019) and control 
groups (p=0.004). In summary, CD8+ EMRA were the only CD8+ T cells subset mobilised by 
vigorous intensity exercise in both the T1D and control group. However, the percentage 
increase post vigorous intensity exercise is much lower in the T1D group (control: 66.67%, 
T1D: 26.45%) suggesting a blunted egress of CD8+ EMRA during exercise in T1D (Figure 
2); however, no significant time*group differences were observed. 
Vigorous intensity exercise mobilises fully differentiated CD8+ EMRA T cells expressing 
markers of activation and adhesion in T1D and control participants, with evidence of a 
blunted response in T1D 
A number of cell surface markers were measured on CD8+ T cells to define the homing 
propensity and function of circulating CD8+ populations in T1D and control participants. 
These were examined on naïve, CM, EM, and EMRA CD8+ T cell subsets. These markers 
included CD69 (a marker of activation and tissue-resident populations), CD11b (an adhesion 
marker involved in lymphocyte migration), CD127 (IL-7R, necessary for memory CD8+ T 
cell maintenance), and CD95 (expressed on memory subsets and a marker of apoptosis). The 
combination of CD27 and CD28 expression was used to define the differentiation status of 
CD8+ EMRA subsets. Conventionally EMRA are defined as CD27-CD28-. However, more 
recently further subdivisions of EMRA differentiation based on the differential expression of 
CD27 and CD28 have been described and also shown in this study herein [14, 15]. 
As described earlier, CD8+ EMRA are the only subsets which are significantly mobilised in 
both T1D and control participants. Interestingly, the percentage increase of CD8+ EMRA T 
 13
cells is blunted in T1D. Further phenotyping of CD8+ EMRA T cell subsets using the surface 
markers described above show that CD8+ EMRA expressing markers of activation and tissue 
residency (CD69), homing propensity (CD11b), and are the most differentiated (CD27-CD28-
) are significantly mobilised by acute vigorous intensity exercise in both groups. Again, the 
percentage increase of these CD8+ EMRA T cell subsets is blunted in T1D compared to 
control participants. No significant mobilisation was observed for CD8+ EMRA expressing 
CD127 or CD95 in either group independently. The results for the above cell surface markers 
on CD8+ lineage subsets during vigorous intensity exercise in T1D and control participants 
are displayed in table 3 and described below. 
Vigorous intensity exercise significantly mobilised all but naïve subsets expressing CD69. 
The most profound effect was observed CD8+ EMRA T cells expressing CD69. Vigorous 
intensity exercise resulted in the mobilisation of CD8+CD69+ EMRA T cells in T1D 
(p=0.002) and control groups (p=0.003), with a significant increase immediately post-
exercise observed in the control group only (p=0.010). The percentage increase was blunted 
in the T1D group following vigorous (T1D: 29.87%, Control: 161.43%) intensity exercise 
(table 3).   
Likewise, the most profound effect on CD8+ T cell subsets expressing CD11b was observed 
for the EMRA. Vigorous intensity exercise significantly mobilised CD8+ EMRA T cells 
expressing CD11b in T1D (p=0.007) and control groups (p=0.001), with no significant 
changes in CD8+CD11b+ naïve, CM, or EM subsets during vigorous exercise in either group. 
There was a significant increase immediately post-exercise in the control group only 
(p=0.010). However, in the T1D group, this subset significantly decreased below baseline 1 
hour post vigorous exercise (p=0.006). The percentage increase of CD8+CD11b+ EMRA was 
blunted in the T1D group following vigorous intensity exercise (T1D: 37.70%, Control: 
91.48%) (table 3). 
Lastly, fully differentiated CD8+ EMRA (CD27-CD28-) were the only subset of EMRA to 
significantly mobilise both the T1D (p=0.050) and control group (p=0.037) independently. 
The percentage increase post vigorous exercise was considerably blunted in the T1D group 
(T1D: -7.02%, control: 113.76%). There was a significant decrease below baseline 1 hour 
post vigorous intensity exercise in the T1D group only (p=0.005).  
 14
Vigorous intensity exercise mobilises CD4+ T-Regulatory cells, mainly comprised of 
memory T-Regulatory cells, in control but not T1D participants 
Vigorous intensity exercise mobilises CD4+ T cells in control but not T1D participants 
(supplementary table 1). A similar pattern was observed for CD4+ lineage subsets 
(supplementary table 2-3). Significant mobilisation patterns were also observed within the 
CD4+ T-Regulatory and T-helper subsets, and is described below. 
Total CD4+ T-Regulatory cells (CD127loCD25hi), and the naïve (CD45RO-CD127loCD25hi) 
and memory (CD45RO-CD127loCD25hi) compartment, were measured during vigorous 
intensity exercise in T1D and control participants. The results are displayed in table 4. CD4+ 
TReg subsets were significantly mobilised by vigorous intensity exercise overall (p=0.010) 
and in control (p=0.009) but not T1D participants. There was a significant decrease below 
baseline 1 hour post-exercise overall (p=0.038), but this was not seen in either T1D or control 
groups independently (Figure 3a). The percentage change following exercise was much lower 
in the T1D compared to the control group (T1D: 23.74%, Control: 47.65%). Further 
delineation of CD4+ TRegs revealed that memory TReg subsets were significantly mobilised 
by vigorous intensity exercise overall (p=0.004) and in the control group (p=0.006) (Figure 
3b). There was a significant decrease below baseline overall 1 hour post-exercise (p=0.042), 
but this was not seen in either T1D or control group independently. Naïve TReg subsets did 
not significantly mobilise (Figure 3c).  
Th1 (CXCR3+CCR6+CCR4-), Th2 (CXCR3-CCR6-CCR4+), and Th17 (CXCR3-
CCR6+CCR4+) cells were measured during vigorous intensity exercise in T1D and control 
participants. The results are displayed in table 4. Vigorous intensity exercise mobilised CD4+ 
Th2 cells in control but not T1D participants. However, neither CD4+ Th1 or Th17 cells 
significantly mobilised in either control or T1D groups independently. In summary, CD4+ T-
helper subsets do not significantly mobilise in T1D participants. However, some mobilisation 
of Th2 subsets were observed in control participants, shifting the Th1/Th2 ratio towards anti-
inflammatory subsets. Th2 subsets significantly mobilised during vigorous intensity exercise 
in control (p=0.042) but not T1D participants, with a significant increase post-exercise in the 
control group (p=0.039).  
DISCUSSION 
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This study has, for the first time, characterised the effects of acute exercise on the 
mobilisation of T cell subsets in people with T1D. The use of surface markers to define T cell 
function and fate improves understanding of the specific subpopulations mobilised during 
exercise in a T cell mediated autoimmune disease characterised by profound T cell 
involvement.  
Acute exercise causes an intensity-dependent lymphocytosis in people with T1D. Total 
lymphocytes, including CD3+ T cells are mobilised in both T1D and control participants. 
This agrees with previous studies where vigorous exercise induces a significant rise in 
peripheral blood lymphocytes, followed by lymphopenia, in healthy cohorts [48, 56-58, 80]. 
Within the T cell compartment, CD4+ T cells mobilised during vigorous exercise in the 
control group, but not the T1D group. This had a downstream effect on CD4+ T cell subsets 
in T1D participants because no significant mobilisation of differentiated CD4+ T cell lineage 
subsets was observed during exercise. In agreement with previous studies, the changes seen 
during exercise within the CD4+ compartment were minimal compared to changes seen 
within the CD8+ compartment [50, 51].  
Vigorous intensity exercise significantly mobilised CD8+ T cells in both T1D and control 
participants. CD8+ T cells increased to the same extent after vigorous intensity exercise in 
both the T1D and control group. As reported in previous studies, CD8+ EMRA were the most 
sensitive T cell subset to mobilisation, and are shown to mobilise by vigorous exercise in this 
study herein and others [50-52]. However, the percentage increase of CD8+ EMRA in the 
T1D group following vigorous intensity exercise was blunted. Further phenotyping of CD8+ 
EMRA populations revealed that the mobilised subsets mainly comprised of fully 
differentiated (CD27-CD28-), recently activated tissue-resident (CD69+) EMRA with 
migratory capacity (CD11b+). Again, the percentage increase of these CD8+ EMRA subsets 
following vigorous exercise was blunted in the T1D group. To the best of our knowledge, this 
is the first time this effect has been described in T1D. 
Furthermore, the effects of exercise on TSCM subsets have not been previously examined. This 
is the first time this has been investigated in T1D and healthy cohorts. Although no 
significant changes overtime for either CD4+ or CD8+ TSCM were found, a trend to increase 
following vigorous intensity exercise as shown by percentage increase was observed in 
healthy participants. Furthermore, an impaired response in T1D was noted for CD4+ and 
CD8+ TSCM subsets, with both subsets decreasing following vigorous intensity exercise.  
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In this study, we used additional cell surface markers to define the function and fate of CD4+ 
and CD8+ T cell lineage subsets. Increases in both CD69 and CD11b on CD4+ and CD8+ 
lymphocytes have been reported following exercise previously, but not on specific T cell 
subsets as demonstrated in this study herein [57, 81-89]. An increase in CD4+ and CD8+ T 
cell lineage subsets expressing CD69 is evident in both groups, with a larger percentage 
increase post-exercise observed in healthy participants. CD4+ and CD8+ T cell lineage 
subsets expressing CD11b is also noted following exercise in both groups. However, the 
percentage increase post-exercise in the T1D participants is smaller. CD95+ memory T cells 
are known to mobilise following vigorous intensity exercise in healthy participants [60, 63]. 
In our study, CD95+ EM and EMRA T cells from both the CD4+ and CD8+ compartments 
increased immediately post-exercise, however this increase did not reach statistical 
significance. Again, it is evident that this response is blunted in T1D as the percentage 
increase following vigorous intensity exercise is much lower than that of the control group.  
There are a number of potential reasons for this blunted response in T1D. Firstly, blood 
glucose levels are elevated in people with T1D (above 5mM) during and following. High 
glucose conditions affect the mobilisation of several cell types and therefore may affect 
lymphocytosis. Elevated plasma glucose in T1D and T2D rodent models have been reported 
to impair CD34+ HSPC, CD45+, and fibroblast cell migration [90, 91]. Furthermore, fewer 
lymphocytes were found in the wound site of streptozotocin-induced diabetic mice compared 
to control, suggesting lower migration of lymphocytes in T1D [92]. Therefore, high glucose 
levels in T1D may have an effect on T cell migration during exercise. 
Secondly, the T cell subsets which exhibit blunted lymphocytosis during vigorous exercise in 
T1D are those which typically exhibit a high level of beta-adrenergic receptor expression. It 
is recognised that catecholamine responses can be blunted in T1D. Natural killer (NK) cells 
and cytotoxic T lymphocytes express much higher levels of beta-adrenergic receptors than 
other mononuclear cells, causing their dramatic mobilisation during exercise [93-96]. 
Alterations in these receptors in T1D would alter the stress response to exercise. Reduced 
beta-adrenergic sensitivity of lymphocytes in T1D has been reported, resulting in a dampened 
adrenaline response [97-99]. During acute exercise, increased beta-adrenoceptor density and 
sensitivity of lymphocytes is noted in healthy participants. However, patients with congestive 
heart failure (CHF) exhibited a blunted increase in beta-adrenoceptor density and no increase 
in sensitivity [100]. A similar effect may be seen in T1D and may impact exercise-induced 
lymphocytosis.  
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Lastly, the T cell subsets exhibiting blunted lymphocytosis during vigorous exercise share 
characteristics with those sequestered in the T1D pancreas [6, 7, 101, 102]. These include 
CD8+CD69+ T cells [101, 103], CD8+CD11b+ T cells [6, 7], and highly differentiated 
memory T cells [2, 4, 8]. The proportion of CD8+CD69+ T cells was higher in the pancreas 
than salivary glands taken from NOD mice [101]. CD8+CD11b+ T cells have also been found 
within NOD islets [6, 7] and found to be higher in the islets of NOD mice compared to 
peripheral blood [102]. Furthermore, antigen-experienced islet reactive CD8+ T cells were 
found sequestered in the pancreas of T1D donors [4]. Islet reactive CD8+ T cells have been 
shown to exhibit a highly differentiated memory phenotype [2, 8], similar to the CD8+ 
EMRA T cell phenotype. More recently, islet specific CD8+ T cells were shown to display a 
TSCM phenotype. In our study, lymphocytosis of highly differentiated CD8+ EMRA that 
express CD69 and CD11b was blunted immediately following vigorous exercise in T1D. 
Both CD4+ and CD8+ TSCM also displayed a blunted percentage increase following vigorous 
exercise compared to the control group. It therefore is possible to postulate that the blunted 
increase following exercise in these CD8+ T cell subsets is due to their sequestration in the 
pancreas in T1D.  
The results of our study have a number of implications for T1D. Firstly, this study provides  
imperative evidence of the effects of acute exercise on immunity in people with T1D. 
Importantly, this provides a platform for future investigations of exercise in T1D, allowing 
for new avenues to be explored to increase the initial honeymoon phase following diagnosis 
[104], reduce disease severity, and ultimately for the treatment of T1D. Acute exercise has 
the potential to regulate immunity in T1D through increased immunosurveillance, deletion of 
islet reactive T cells and thereby creation of immune space. Lymphocyte trafficking and 
tissue redistribution is essential for immunosurveillance and regulation [58, 59]. The deletion 
of exercise sensitive EM and EMRA CD8+ T cells following acute exercise has the potential 
to regulate immunity through the creation of “immunological space” in people with T1D [60-
65]. This immune space following exercise could be taken up by newly generated HSPC and 
reprogram immune memory [66, 67], thereby reducing aggressive memory T cell phenotypes 
and ultimately modulating beta cell autoimmunity in T1D. 
Furthermore, acute exercise could be used in combination with current trial immunotherapies, 
and possibly boost the response to immunotherapeutic agents, which to date have been 
lacking for treatment of T1D. Some immunotherapeutic approaches to modulate beta cell 
autoimmunity in T1D aim to reduce aggressive memory phenotypes and promote the 
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generation of new naïve cells in T1D. This has been achieved previously with both acute 
exercise and exercise training in healthy cohorts. Therefore, exercise in T1D may be used as 
an adjunct for other immunotherapeutic agents. One such immunotherapy, teplizumab, a 
nonactivating anti-CD3 monoclonal antibody, aims to reduce effector memory subsets, and 
increase naïve and early memory subsets. This could potentially also be achieved solely by an 
acute exercise bout or used to boost target T cell populations by administering the treatment 
directly after an acute exercise bout. Anti-CD3 mAbs that are non-Fc receptor (FcR) binding, 
like teplizumab, selectively induce apoptosis of antigen-activated T cell phenotypes such as 
those with memory/pathogenic phenotypes but not naïve T cells [105]. Teplizumab treatment 
resulted in maintained or improved beta cell function for at least 2 years post treatment in 
recent-onset T1D patients [106-109]. Evidence for beta cell preservation was also reported in 
long standing T1D patients up to 1 year post clinical diagnosis [110]. One study identified a 
group of responders who had higher activated CD8+ terminally differentiated effector and 
CD8+ EM in T cells at baseline [111]. This is consistent with increased CD8+ terminally 
differentiated EM T cells following acute exercise.  Therefore, frequent bouts of acute 
exercise could create an environment in which T1D participants respond better to treatment.  
Preliminary data from this study herein also provides a basis to investigate exercise training 
(as opposed to a single bout of exercise) in T1D. Chronic exercise reduces senescent T cells 
in the blood [112]. In an ageing study, physically fit age matched controls had a lower 
proportion of peripheral blood memory T cells (KLRG1+CD57+, KLRG1+CD28-) compared 
to those with a lower VO2 max [65, 113]. Naïve-memory T cell balance is disrupted in the 
ageing population and a similar observation has been found in T1D [114]. Therefore, reduced 
senescent memory T cell populations may also occur from exercise training in T1D.  
The mechanisms by which exercise training could preserve beta cells in T1D have yet to be 
explored. Evidence of immunomodulation by exercise training in T1D is limited. Two studies 
to date have examined exercise training in T1D mouse models.  The first study showed that 6 
weeks of exercise training in streptozotocin-induced T1D mice significantly improved insulin 
content and insulin secretion in islets compared to sedentary mice, suggesting a protective 
effect against the destruction of the remaining beta cells or the generation of new beta cells 
[68]. A more recent study has examined the effects of exercise training on immune 
parameters in T1D [69]. Twenty weeks of training in non-obese diabetic (NOD) mice 
resulted in reduced immune cell infiltration into the pancreas and subsequently the insulitis 
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index. This is the only exercise study in a model of T1D to demonstrate the modulatory 
effects of exercise on islet immunity [69].  
Although not well studied in T1D, exercise training has been demonstrated to modulate 
immunity in other T cell mediated autoimmune disorders [115]. Mice with EAE, a model for 
multiple sclerosis (MS), underwent 6 weeks exercise training. T cells taken from lymph 
nodes had an inhibited immune response to autoantigen whilst sustaining an increased 
immune response to non-specific stimulus such as concanavalin A [115]. This suggests the 
generation of new naïve and early memory T cells with exercise training as the recall 
response to autoantigen is reduced. Another study showed improved immune modulation by 
exercise in EAE models resulting in delayed onset of disease and increased T cells with a 
regulatory phenotype [116]. However, other autoimmune disorders such as rheumatoid 
arthritis (RA) and systemic lupus (SLE) have different responses to exercise, where CD8+ T 
cells are reduced following exercise and CD4+ T cells are reduced at peak exercise but 
increased after cessation [117]. It is unclear if exercise training (as opposed to a single bout 
of exercise) would result in responses to exercise that are comparable to healthy participants.  
In conclusion, we show for the first time that acute exercise preferentially mobilises 
differentiated and antigen experienced CD8+ T cells in T1D, but to a lesser extent than in 
healthy individuals. A contributing factor to the relatively reduced mobilisation pattern in 
T1D was attributable to a blunted response among highly differentiated CD8+ T cells, which 
may indicate sequestering of CD8+ T cells in the pancreas. These findings need to be 
extended and investigated in an exercise training programme, and the functional implications 
of this effect on beta cell function explored in a formal clinical trial.  
We have previously hypothesised that an exercise training programme has the potential to 
modulate beta cell loss in people newly diagnosed with T1D [118]. We have tested this 
hypothesis in a pilot randomised controlled trial [119, 120]. This study showed that beta cell 
function, when corrected for the changes in insulin sensitivity that accompany physical 
exercise, appears to be preserved in people with T1D. The results of this most recent work 
exploring the effect of a single bout of exercise on T cell mobilisation provides mechanistic 
insight into how exercise may bring about a benefit to beta cell health in people newly 
diagnosed with T1D. Further evaluation of the immunomodulatory effects of acute exercise 
on autoreactive memory T cells in T1D is warranted to ascertain impact on disease prognosis. 
These findings need to be validated in an exercise training study. 
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Abbreviations 
BMI Body Mass Index 
BP Blood Pressure 
CA2+ Calcium 
CCL Chemokine Ligand 
CCR Chemokine Receptor 
CD Cluster of Differentiation 
CMV Cytomegalovirus 
CTL Cytotoxic T Lymphocyte 
CXCR C-X-C chemokine receptor 
ddH2O Double-distilled water 
ED Early Differentiated 
EDTA Ethylenediaminetetraacetic Acid  
ELD Early-like Differentiated 
EM Effector Memory 
EMRA Effector Memory  re-expressing CD45RA 
EXTOD Exercise for Type One Diabetes 
FBS Fetal Bovine Serum 
FcR Fc Receptor 
FMO Fluorescence Minus One 
FoxP3 Forkhead winged helix transcription factor 
FSC-A Forward Scatter-Area 
FSC-H Forward Scatter-Height 
HbA1c Haemoglobin A1c  
HSPC Hematopoietic Stem and Progenitor Cells  
ID Intermediately Differentiated 
KLRG1 Killer cell Lectin-like Receptor subfamily G member 1  
mAb Monoclonal antibody 
mTReg memory T-Regulatory 
naTReg Naïve T-Regulatory 
NK Natural Killer 
O2 Oxygen 
PBS Phosphate Buffer Saline 
pTReg periphery T-Regulatory cell 
REC Research Ethics Committee 
S1PR Sphingosine-1-Phosphate Receptor  
sIL2RA soluble IL2RA 
sIL-6R soluble IL-6R 
SSC-A Side Scatter- Area 
SSC-H Side Scatter- Height 
T1D Type 1 Diabetes 
T2D Type 2 Diabetes 
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Th1 Type 1 helper  
Th2 Type 2 helper  
Th17 Type 17 helper  
TIGIT T cell immunoreceptor with Ig and ITIM domains  
TReg T-Regulatory 
TSCM Stem cell like memory T cells 
UHBFT University Hospitals Birmingham NHS Foundation Trust 
WTCRF Wellcome Trust Clinical Research Facility 
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